CloseX
CloseX
Public Site >Sign In  | Register
My Cart
My Cart Summary
Mandatory items may have been added.

< GAIN FROM OUR PERSPECTIVE>

Franklin Focused Core Equity Fund

Fund Category: BlendGo to Prices & Performance page
showing this category of funds.

Share This Page
Symbol FCEQX
CUSIP 354 713 448
Fund Number 443
Inception Date1 Dec 13, 2007
Distributions Annually
Total Net Assets
(all share classes)
As of 07/31/2015
$196.3
(millions)

As of  08/27/2015

NAV2 $14.80  
NAV Change $0.36  
POP3 $15.70  
YTD Total Return at NAV 2.49%
Distribution Rate at NAV N/A
30-day Standardized Yield
N/A

Average Annual Total Returns
As of Quarter End 06/30/2015

w/ Sales Charge w/o Sales Charge
1 Yr 4.22% 10.55%
5 Yrs 15.44% 16.81%
10 Yrs
Life 6.92% 7.76%

Expense Ratio and Sales Charge As of 09/01/2014 (updated annually)

Gross Expense Ratio4,5 1.73%
Net Expense Ratio 1.30%
Max Initial Sales Charge 5.75%
CDSC 0.00%
12b-1 Fee 0.30%
  • Portfolio Statistics
    Total Fund Assets
    As of 07/31/2015
    (updated monthly)
    $196.3
    (millions)
    Net Assets - Class A
    As of 07/31/2015
    (updated monthly)
    $116.9
    (millions)
    Portfolio Turnover Rate
    As of 04/30/2015
    (updated annually)

    25.55
    P/E Ratio
    As of 07/31/2015
    (updated quarterly)

    23.02
    P/B Ratio
    As of 07/31/2015
    (updated quarterly)

    2.75
    Portfolio Positions
     
    As of 07/31/2015
    Number of Issuers 34

    Detailed Holdings page

Portfolio Details9

Asset Mix

As of 07/31/2015

Top 10 Holdings

As of 07/31/2015

Industry Breakdown

As of 07/31/2015
Pharmaceuticals, Biotechnology & Life Sciences 16.31 %
Software & Services 13.19 %
Diversified Financials 9.89 %
Media 8.73 %
Technology Hardware & Equipment 7.94 %
Energy 7.50 %
Real Estate 5.98 %
Commercial & Professional Services 5.72 %
Transportation 4.76 %
Banks 4.62 %

You need Adobe Acrobat Reader 6.0 or higher to view and print PDF documents. Download a free version from Adobe's website.


Important Legal Information

Footnotes

For US residents only.